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The mechanisms and neural circuits that drive emotion and cognition are inextricably
linked. Activation of the hypothalamic-pituitary-adrenal (HPA) axis as a result of stress
or other causes of arousal initiates a flood of hormone and neurotransmitter release
throughout the brain, affecting the way we think, decide, and behave. This review will
focus on factors that influence the function of the prefrontal cortex (PFC), a brain region
that governs higher-level cognitive processes and executive function. The PFC becomes
markedly impaired by stress, producing measurable deficits in working memory. These
deficits arise from the interaction of multiple neuromodulators, including glucocorticoids,
catecholamines, and gonadal hormones; here we will discuss the non-human primate
and rodent literature that has furthered our understanding of the circuitry, receptors, and
signaling cascades responsible for stress-induced prefrontal dysfunction.
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INTRODUCTION
Our ability to manage, update, and act on information in the
absence of external cues—executive functions collectively known
as working memory—is critical to daily functioning (Arnsten
and Castellanos, 2002). These processes depend on the struc-
tural and functional integrity of the prefrontal cortex (PFC)
(Goldman-Rakic, 1996), a highly evolved brain region that guides
emotion and behavior through projections to subcortical regions
like the hypothalamus, amygdala, and brainstem nuclei (Price
et al., 1996). Under optimal, stress-free conditions, microcir-
cuits within the PFC work together to inhibit inappropriate
responses and allow nuanced decision-making (Goldman-Rakic,
1995). Exposure to stress, however, can disrupt PFC function,
markedly impairing working memory (Arnsten, 2009; Arnsten
et al., 2012). From an ethological standpoint, this loss of com-
plex processing may have once allowed more primitive behaviors
to take precedence in order to aid survival. But today, non-life-
threatening stressors can activate these same circuits, eliciting
scattered thought, loss of focus, and judgment errors that can be
detrimental to daily life, and—in extreme cases—lead to mental
illness. Over the last few decades, animal research has helped elu-
cidate the mechanisms that underlie these impairments, revealing
a complex interaction between neurotransmitter signaling and
hormone actions.
Working memory in animals is assessed using delay-based
tasks, which require an animal to keep a piece of information
in mind over the course of a delay period, in order to make an
accurate choice when the delay ends. Monkeys performing the
Delayed Response task must remember the location of a briefly
presented stimulus on a screen, and then move their eyes to
focus on that location. In rodents, the Delayed Alternation task
requires the animal to remember which arm of a T-shaped maze
it previously visited, and then visit the opposite arm on the sub-
sequent trial. Both tasks involve dozens, or even hundreds of
trials, and thus during the delay the animal must not only keep
the “signal” (i.e., correct choice) in mind, but also suppress the
“noise”—information from previous trials. Subsets of prefrontal
neurons fire exclusively during the delay (Funahashi et al., 1989),
suggesting a unique role for the PFC in this aspect of the task.
Moreover, lesions of the PFC disrupt accuracy only when the
task involves a delay (Funahashi et al., 1993), demonstrating that
the PFC is not involved in the motor or motivational aspects
of these tasks. Accurate performance on working memory tasks
relies on the maintenance of a balanced neurochemical milieu in
the PFC—one that is easily disrupted with exposure to stress.
Many kinds of mild stressors can impair working memory
in animals. The most common stressor for monkeys is a loud
white noise, which also disrupts working memory in humans
(Arnsten and Goldman-Rakic, 1998). Stressors in rodents include
brief restraint stress (Shansky et al., 2006), and administration of
the anxiogenic drug FG-7142, a benzodiazepine inverse agonist
(Shansky et al., 2004). Each of these manipulations activates the
hypothalamic-pituitary-adrenal (HPA) axis, eliciting a cascade
of hormone and neurotransmitter release that alters cognitive
and emotional processes throughout the brain (Cordero et al.,
2003; Mikkelsen et al., 2005). In this review, we will focus on the
contributions of the catecholamines dopamine (DA) and nore-
pinephrine (NE), and their interactions with glucocorticoids and
estrogen.
DOPAMINE AND NOREPINEPHRINE
The primary sources of DA and NE input to the PFC are the
ventral tegmental area (VTA) and locus coeruleus (LC), respec-
tively (Thierry et al., 1992). Selective lesions of these afferents
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impair working memory in monkeys, suggesting that base-
line catecholamine signaling is required for optimal PFC func-
tion (Brozoski et al., 1979). Investigations into the downstream
mechanisms by which these neurotransmitters mediate work-
ing memory—in both stress and non-stress conditions—indicate
critical roles for the DA D1 receptor, and noradrenergic alpha-1
and alpha-2 receptors (Arnsten, 1998a).
The D1 receptor is coupled to the Gs protein, whose stimula-
tion triggers a signaling cascade that involves increases in cyclic-
AMP (cAMP) and protein kinase A (PKA), the effects of which are
discussed below (Arnsten, 2011a,b). Pharmacological blockade of
D1 receptors in both monkeys and rodents impairs performance
on workingmemory tasks (Sawaguchi andGoldman-Rakic, 1991;
Izquierdo et al., 1998), indicating a key role for D1 signaling
in normal PFC function. Electron micrographs show that D1
receptors co-localize with glutamate receptors on dendritic spines
(Pickel et al., 2006, and see Figure 1), making them strategi-
cally positioned to modulate incoming excitatory information.
Single unit physiological studies inmonkeys performing a delayed
response task have revealed that D1 activity plays an integral
role in filtering out “noise”—suppressing firing in PFC neurons
that code for information irrelevant to the immediate task, thus
increasing the likelihood of a correct response (Vijayraghavan
et al., 2007). Without D1 stimulation, PFC neurons become gen-
erally overactive, rendering the animal vulnerable to distractions
(Vijayraghavan et al., 2007).
While a lack of D1 activity can impair working memory
performance, high levels of D1 stimulation also produce cogni-
tive deficits—the classic “inverted-U” relationship. During stress,
HPA axis activation leads to stimulation of the VTA, causing
excess DA release into the PFC (Murphy et al., 1996). When
this DA binds to the D1 receptor, its downstream signaling cas-
cades lead to working memory impairment (Taylor et al., 1999).
Accordingly, these impairments can be reversed by intra-PFC
infusions of a D1 antagonist (Zahrt et al., 1997), as well as by
infusions of cAMP and PKA inhibitors (Taylor et al., 1999).
Physiologically, elevated D1 signaling leads to a suppression of
not only “noise”-related neurons, but of “signal” neurons as
well (Vijayraghavan et al., 2007)—the information is lost, and
the PFC is unable to accurately guide behavior. Moreover, this
general silencing of neuronal activity loosens the PFC’s regula-
tory influence over subcortical structures, allowing amplified and
protracted emotional responses (Arnsten, 1998b).
How does this switch take place on a cellular level? Recent work
has revealed a critical role for hyperpolarization-activated/cyclic
nucleotide-gated (HCN) ion channels, which co-localize on
dendritic spines with D1 receptors (Paspalas et al., 2012).
Traditionally, HCN channels serve to normalize neuronal mem-
brane potential, opening to allow positive ions into the cell
to combat post-firing hyperpolarization (Wahl-Schott and Biel,
2009). But as their name implies, HCN channels are also sen-
sitive to changes in cAMP levels, and when cAMP increases (as
happens when D1 receptors are over-activated), HCN channels
open, letting Na+ and K+ flow out of the cell (Chen et al.,
2007). The net effect of this efflux is a lessening of the likeli-
hood that an incoming stimulus will be sufficiently excitatory
to propagate an action potential, thus forming the physiological
basis of D1-driven information loss. Pharmacological blockade of
HCN channels restores working memory performance and PFC
network tuning during stress or after administration of a D1 ago-
nist, demonstrating a functional link between these channels and
upstream changes in DA signaling (Arnsten, 2011b).
HCN channel activity is also modulated by the noradrenergic
alpha-2 receptor. This receptor is coupled to Gi, the activation
of which results in a decrease in cAMP. This causes a slowing
of HCN channel conductance, thus preserving incoming excita-
tory input. In this way, the alpha-2 receptor acts to strengthen
PFC network activity, enhancing the “signal” for relevant infor-
mation, while as noted above, the D1 receptor suppresses “noise”
(Wang et al., 2007). Thus, under optimal conditions, the D1
and alpha-2 receptors work together to fine-tune PFC neuronal
firing. Pharmacological stimulation of the alpha-2 receptor can
increase firing in PFC neurons that code for relevant infor-
mation, enhancing working memory in monkeys and rodents
(Wang et al., 2007). Additionally, alpha-2 agonists reverse work-
ing memory impairments that occur during stress (Birnbaum
et al., 2000).
Alpha-2 receptors have a high affinity for NE, and are pri-
marily bound and active during non-stress conditions (O’Rourke
et al., 1994). Under stress, however, the LC releases NE through-
out the brain and excess NE in the PFC binds instead to the lower-
affinity alpha-1 receptor (Mohell et al., 1983). Stimulation of this
receptor—either pharmacologically or because of stress-induced
NE release—leads to working memory impairment and a silenc-
ing of PFC network activity (Arnsten et al., 1999). Conversely,
administration of an alpha-1 antagonist can restore PFC func-
tion and neuronal firing during stress (Birnbaum et al., 1999).
The impairing effects of alpha-1 stimulation are due in part to
downstream activation of protein kinase C (PKC), the inhibi-
tion of which also reverses stress-related impairments on working
memory tasks in monkeys and rodents (Birnbaum et al., 2004).
The PKC pathway inhibits neuronal firing through the cleav-
age of membrane phoshoplipase C (PLC), which initiates phos-
phatidylinositol signaling (Birnbaum et al., 2004). Downstream,
intracellular stores of Ca2+ travel to the soma and inhibit neu-
ronal firing through opening of local K+ channels (Hagenston
et al., 2008).
In summary, stress disrupts working memory by eliciting cate-
cholamine release into the PFC, moving both DA and NE levels to
the far end of their respective inverted U curves. Through DA D1
and NE alpha-1 receptor signaling, delay-related neuronal activity
in the PFC is suppressed, and information critical to accurate task
performance is lost (Figure 1). Because the PFC also helps to shut
down the stress response, this loss of PFC function can lead to
prolonged glucocorticoid release, which can exacerbate working
memory impairments.
GLUCOCORTICOIDS
During emotional and stressful situations, activation of the HPA
axis causes the adrenal cortex to release glucocorticoids, which
travel through the bloodstream and cross the blood-brain bar-
rier to activate glucocorticoid receptors (GRs) throughout the
brain (De Kloet et al., 2005). While this release is critical to the
enhancement of long term memories associated with the event
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FIGURE 1 | Model for catecholamine modulation and stress-induced
impairment of working memory. Under stress-free conditions (top),
the noradrenergic alpha-2 receptor drives activity in the prefrontal
cortex by suppressing cAMP levels and strengthening the signal from
incoming information. Under stress (bottom), overstimulation of the
dopamine D1 receptor activates cAMP, causing HCN channels to open,
resulting in a shunting of incoming excitation. Additionally, stimulation
of NE alpha-1 receptors activates a PLC signaling cascade that causes
further loss of excitation through K+ channels in the soma. This leads
to a loss of information, and working memory failure. Adapted from
Arnsten (2009) and Arnsten et al. (2012). Abbreviations: Glu, glutamate;
NMDA, N-methyl D-aspartic acid receptors; NE, norepinephrine; DA,
dopamine; HCN, hyperpolarization nucleotide-gated channels; PLC,
phospholipase C.
(Rodrigues et al., 2009), glucocorticoid actions in the PFC impair
working memory. Systemic injection of corticosterone in rats sig-
nificantly reduces Delayed Alternation accuracy, and infusion of
the GR agonist RU 28362 into the PFC similarly impairs working
memory (Roozendaal et al., 2004). Finally, intra-PFC infusion of
the GR antagonist RU 38486 reverses stress-induced impairments
on the delayed spatial win-shift (DSWS) task, another test of
prefrontal-dependent executive function (Butts et al., 2011).
These findings suggest that glucocorticoids can impair PFC func-
tion through direct actions at GRs, but glucocorticoids may
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also indirectly exacerbate working memory impairments through
interactions with the catecholamine systems described above.
One mechanism of interaction between glucocorticoids and
catecholamines is the extraneuronal catecholamine transport sys-
tem. These transporters are located on glia, and remove excess
DA and NE from the synapse, helping to keep balanced and opti-
mal stimulation of dopaminergic and noradrenergic receptors.
Corticosterone blocks catecholamine transporters in the PFC
(Gründemann et al., 1998), resulting in increased extracellular
catecholamine levels. In this way, stress-induced glucocorticoid
release in the PFC could lead to overstimulation of the both
dopamine D1 and α1 noradrenergic receptors, thus producing
PFC dysfunction.
Glucocorticoids also modulate dopaminergic transmission in
the PFC. Dopaminergic cells in the VTA and PFC express GRs
that become saturated during stress (Ahima and Harlan, 1990),
altering the firing of dopaminergic projections. Interestingly, glu-
cocorticoid effects on DA release in the PFC appear to be locally
driven, rather than a result of actions in the VTA itself. In vivo
microdialysis experiments show that an infusion of GR antago-
nist RU-38486 into the PFC suppresses stress-induced DA release,
but infusions into the VTA have no effect (Butts et al., 2011).
Therefore, GRs play a role specific to the PFC in modulating the
magnitude of stress-induced DA efflux.
Finally, glucocorticoids may further exacerbate catecholamine
effects by activating some of the same intracellular signaling
pathways. As described above, α1 noradrenergic receptor stim-
ulation during stress impairs PFC working memory through
PKC intracellular signaling pathways (Birnbaum et al., 1999).
Glucocorticoid release can also activate PKC signaling (ffrench-
Mullen, 1995), thus potentially amplifying the effects of alpha-1
stimulation.
SEX DIFFERENCES AND ESTROGEN EFFECTS
The vast majority of behavioral neuroscience research is con-
ducted in male animals, and thus our general understanding
of stress effects in the PFC is within the context of the male
brain. From a translational standpoint, this is problematic; stress-
related mental illnesses like post-traumatic stress disorder (PTSD)
and major depressive disorder are twice as prevalent in women
(Becker et al., 2007), suggesting a distinct neurobiology may
underlie the stress response in female brains. Though the exact
mechanisms have not yet been fully identified, a growing body
of literature points to an important role for estrogen in modu-
lating the neurotransmitter and glucocorticoid effects described
above.
One of the first studies to investigate sex differences in stress-
induced working memory impairments used the anxiogenic drug
FG7142 to generate dose-response curves in male and female
rats (Shansky et al., 2004). While T-maze performance declined
with increasing doses in both sexes, females became impaired
after lower doses of FG7142 than those required to impair males.
When the authors divided the females based on estrus cycle phase,
they found that this stress sensitivity was driven by females in
proestrus, when estrogen levels are highest. Similar results were
found after using increasing durations of restraint stress instead of
FG7142 (Shansky et al., 2006), demonstrating generalizability of
the effect, and providing evidence against a simple hormone-drug
interaction.
Further support for the idea that high estrogen levels con-
fer sensitivity to stress comes from studies in ovariectomized
(OVX) female rats. OVX surgery removes circulating estrogen
and progesterone, hormones that can be re-introduced via a sub-
cutaneous time-release silastic capsule. After administration of
low doses of FG7142, OVX rats with long-term estrogen replace-
ment (OVX+ E) demonstrate working memory impairments
that are similar to those of females in proestrus, while OVX
females with a blank capsule perform more like males—impaired
only at higher doses (Shansky et al., 2009). In all of the above
studies, high- and low-estrogen groups did not differ in baseline
working memory performance, suggesting that estrogen does not
directly mediate PFC function, but instead modulates the factors
that contribute to stress-induced impairments. The mechanisms
by which estrogen does this are not known, but several intriguing
possibilities exist.
First, estrogen may exacerbate the effects of stress-induced
glucocorticoid release. Female rats in proestrus have higher
baseline serum corticosterone levels than males or females in
diestrus, and females have a more robust corticosterone response
to acute stress than males do (Mitsushima et al., 2003). Thus,
females with high estrogen levels may be primed for an ampli-
fied corticosterone surge after exposure to lower levels of stress,
eliciting working memory impairments through the mecha-
nisms described above—either through direct actions at GRs, or
through blockade of extraneuronal catecholamine transporters.
To date, however, estrogen-glucocorticoid interactions have not
been investigated in the context of stress-induced working mem-
ory impairments.
Another means by which estrogen may sensitize the PFC to
the detrimental effects of stress is through the dopaminergic sys-
tem. Estrogen increases the physical number of dopaminergic
projections from the VTA to the PFC (Kritzer and Creutz, 2008)
and enhances extracellular DA concentrations (Xiao and Becker,
1994), putting it in a powerful position to modulate working
memory. While these elevated DA levels may not have measur-
able behavioral outcomes on their own, they could indicate that
high-estrogen females are “ahead of the curve” with respect to
the D1-PFC function inverted U. In this scenario, mild stress
merely pushes low-estrogen females just over the top of the U,
while bumping high-estrogen females into impairment ranges.
This hypothesis is illustrated in Figure 2.
The effects of elevated D1 signaling in high-estrogen females
may be further exacerbated through estrogen’s interactions with
noradrenergic alpha-2a receptors. As described in the first section
of this review, alpha-2a activity leads to decreased cAMP pro-
duction and a closing of HCN channels, resulting in enhanced
“signal” in PFC neurons coding for relevant information. This
could serve to combat excess D1 activity, which leads to an
opening of HCN channels, and a loss of information. Estrogen
uncouples the alpha-2a receptor from its G-protein (Ansonoff
and Etgen, 2001), thus potentially disrupting the delicate bal-
ance of D1 and alpha-2a activity that is required for optimal
PFC function. In support of this idea, a dose of guanfacine (an
alpha-2a agonist) that rescues stress-induced working memory
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FIGURE 2 | Estrogen “ahead of the curve” hypothesis. Estrogen
may amplify the stress response in females by raising baseline
dopamine D1 signaling, thus making small shifts more apparent in
behavioral measures. In this model, high- and low-estrogen females
perform equally well at working memory tasks under no-stress
conditions, but mild stress shifts high-estrogen animals down into the
far end of the D1 inverted U, while only pushing low-estrogen animals
slightly across the middle.
impairments in males and OVX female rats has no effect in OVX
rats with estrogen replacement (Shansky et al., 2009).
CONCLUSIONS
Stressful events can lead to immediate and marked impairments
in working memory, an executive function that depends on
a balanced neurochemical state in the PFC. Research in non-
human primates and rodents has shown that this impairment
is driven by increased catecholamine signaling, which may be
further modulated or exacerbated by changes in steroid hor-
mone levels. Beyond stress, this work has provided critical insight
into the mechanisms that underlie PFC function in general, and
the potential for clinical application is substantial. Numerous
mental illnesses—including Major Depressive Disorder, PTSD,
Schizophrenia, and Attention Deficit/Hyperactivity Disorder
[ADHD (Arnsten, 2007)]—are characterized by PFC dysfunc-
tion, and the pathways elucidated by the animal research
described here are currently being targeted in pharmacological
therapies. For example, the NE alpha-1 antagonist prazosin has
been reported to be an effective treatment for PTSD (Berger et al.,
2009), and the alpha-2 agonist guanfacine is used as an alternative
to psychostimulant treatment for ADHD (Bidwell et al., 2011).
Continued investigation into the neuromodulators that influence
working memory—particularly in female populations—could
lead to more nuanced and effective treatments for disorders that
compromise prefrontal function.
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